119 related articles for article (PubMed ID: 1852248)
1. [Utility of proton magnetic resonance spectroscopy in the diagnosis of human brain tumors].
Yoshida Y; Yoshioka Y
No Shinkei Geka; 1991 May; 19(5):421-7. PubMed ID: 1852248
[TBL] [Abstract][Full Text] [Related]
2. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.
Cheng LL; Chang IW; Louis DN; Gonzalez RG
Cancer Res; 1998 May; 58(9):1825-32. PubMed ID: 9581820
[TBL] [Abstract][Full Text] [Related]
3. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
4. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
Kinoshita Y; Yokota A
NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109
[TBL] [Abstract][Full Text] [Related]
5. [Proton magnetic resonance spectroscopy in diagnostics of tumorous and nontumorous lesions in brain].
Podoprigora AE; Pronin IN; Fadeeva LM
Zh Vopr Neirokhir Im N N Burdenko; 2000; (3):17-20; discussion 20-1. PubMed ID: 11221336
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas.
Morales H; Kwock L; Castillo M
J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777
[TBL] [Abstract][Full Text] [Related]
8. Metabolic information from the human fetal brain obtained with proton magnetic resonance spectroscopy.
Kok RD; van den Bergh AJ; Heerschap A; Nijland R; van den Berg PP
Am J Obstet Gynecol; 2001 Nov; 185(5):1011-5. PubMed ID: 11717623
[TBL] [Abstract][Full Text] [Related]
9. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy imaging in the study of human brain cancer.
Martínez-Bisbal MC; Celda B
Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):618-30. PubMed ID: 20016453
[TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopy of brain tumors: an in vitro study.
Kinoshita Y; Kajiwara H; Yokota A; Koga Y
Neurosurgery; 1994 Oct; 35(4):606-13; discussion 613-4. PubMed ID: 7808603
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of brain metabolites observed by HRMAS 1H NMR of intact tissue and solution 1H NMR of tissue extracts in SIV-infected macaques.
Ratai EM; Pilkenton S; Lentz MR; Greco JB; Fuller RA; Kim JP; He J; Cheng LL; González RG
NMR Biomed; 2005 Jun; 18(4):242-51. PubMed ID: 15759297
[TBL] [Abstract][Full Text] [Related]
13. Grade classification of neuroepithelial tumors using high-resolution magic-angle spinning proton nuclear magnetic resonance spectroscopy and pattern recognition.
Chen W; Lou H; Zhang H; Nie X; Lan W; Yang Y; Xiang Y; Qi J; Lei H; Tang H; Chen F; Deng F
Sci China Life Sci; 2011 Jul; 54(7):606-16. PubMed ID: 21748584
[TBL] [Abstract][Full Text] [Related]
14. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.
Ziegler A; von Kienlin M; Décorps M; Rémy C
Cancer Res; 2001 Jul; 61(14):5595-600. PubMed ID: 11454713
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
16. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
18. In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors.
Luan W; Zhang J
Chin Med J (Engl); 1998 Jan; 111(1):56-8. PubMed ID: 10322655
[TBL] [Abstract][Full Text] [Related]
19. Differences in metabolic and morphological reactions after radiation therapy: proton NMR spectroscopy and imaging of patients with intracranial tumors.
Ikehira H; Miyamoto T; Yasukawa T; Obata T; Katoh H; Koga M; Yoshikawa K; Yoshida K; Tateno Y
Radiat Med; 1995; 13(5):199-204. PubMed ID: 8848553
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
